Lanean...
Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma
Extrapulmonary neuroendocrine carcinoma (EPNEC) is a lethal disease with a poor prognosis. Platinum‐based chemotherapy is used as the standard first‐line treatment for unresectable EPNEC. Several retrospective studies have reported the results of the utilization of temozolomide (TMZ) as a drug for t...
Gorde:
| Argitaratua izan da: | Cancer Sci |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2021
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088944/ https://ncbi.nlm.nih.gov/pubmed/33453146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14811 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|